Cingulate (CING) vs Nomad Power Solutions (NMAD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cingulate (CING) has outperformed Nomad Power Solutions (NMAD) over the past year, gaining 17.3% versus a loss of 14.5%. Nomad Power Solutions is the larger company by market cap ($71.3 million vs $70.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CING | NMAD |
|---|---|---|
| Share price | $4.88 | $4.43 |
| Market cap | $70.89M | $71.33M |
| 1-day change | +0.10% | +4.34% |
| YTD return | +12.21% | +8.14% |
| 1-year return | +17.35% | -14.49% |
| 5-year return | — | -77.27% |
| EPS (TTM) | $-3.51 | $-1.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.89 | $8.38 |
| 52-week low | $3.16 | $2.36 |
| Distance from 52-week high | -59.00% | -47.14% |
| Average volume | 139.16K | 277.61K |
| Shares outstanding | 14.54M | 16.10M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CING has outperformed NMAD by 31.8 percentage points over the past year.
CING vs NMAD FAQ
Which is bigger, Cingulate or Nomad Power Solutions?
Nomad Power Solutions (NMAD) is larger, with a market capitalization of $71.33M compared with $70.89M for Cingulate (CING).
Which stock has performed better over the past year, CING or NMAD?
CING returned +17.35% over the past 12 months, compared with -14.49% for NMAD (price return, excluding dividends). Past performance does not predict future results.
Are Cingulate and Nomad Power Solutions in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.